Charles River Laboratories Intl (CRL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2002 | 12-2001 | 09-2001 | 06-2001 | 03-2001 | |
| Sales | 133,820 | 126,094 | 123,685 | 116,820 | 99,031 |
| Cost of Goods | 83,861 | 82,486 | 80,474 | 73,050 | 62,369 |
| Gross Profit | 49,959 | 43,608 | 43,211 | 43,770 | 36,662 |
| Operating Expenses | 22,410 | 21,689 | 19,673 | 19,328 | 17,657 |
| Operating Income | 28,410 | 22,405 | 24,012 | 24,492 | 19,374 |
| Interest Expense | 3,905 | 4,443 | 5,456 | 5,940 | 6,958 |
| Other Income | -26,967 | -7,421 | 569 | 360 | 891 |
| Pre-tax Income | -2,462 | 10,541 | 19,125 | 18,912 | 13,307 |
| Income Tax | -992 | 4,381 | 6,677 | 7,659 | 5,555 |
| Net Income Continuous | -2,232 | 5,813 | 11,805 | 10,601 | 7,188 |
| Net Income Extraordinary | N/A | N/A | -1,284 | -1,583 | -237 |
| Net Income | $-2,232 | $8,917 | $10,521 | $9,018 | $6,951 |
| EPS Basic Total Ops | -0.05 | 0.21 | 0.24 | 0.22 | 0.19 |
| EPS Basic Continuous Ops | -0.05 | 0.13 | 0.27 | 0.26 | 0.20 |
| EPS Diluted Total Ops | -0.05 | 0.19 | 0.23 | 0.21 | 0.17 |
| EPS Diluted Continuous Ops | -0.05 | 0.12 | 0.26 | 0.24 | 0.18 |
| EBITDA(a) | $34,218 | $31,933 | $31,492 | $31,437 | $25,266 |